Werewolf Therapeutics (HOWL) Earnings Date & Reports
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HOWL is expected to report earnings to fall 375.00% to -21 cents per share on November 05
Q3'26
Est.
$-0.22
Q2'26
Beat
by $0.36
Q1'26
Missed
by $0.01
Q4'25
Beat
by $0.14
Q3'25
Beat
by $0.02
The last earnings report on July 31 showed earnings per share of 7 cents, beating the estimate of -28 cents. With 489.62K shares outstanding, the current market capitalization sits at 45.20M.